Using microbubbles to increase the destruction of liver tumors by high-intensity focused ultrasound

利用微泡通过高强度聚焦超声增加对肝脏肿瘤的破坏

基本信息

  • 批准号:
    15390228
  • 负责人:
  • 金额:
    $ 8.13万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

We studied the possibility of using high-intensity focused ultrasound (HIFU) together with a microbubble agent to treat hepatocellular carcinoma.The transducer for HIFU was 40 mm in diameter ; it produced a continuous 2.18-MHz wave for 30 seconds.The spatial peak temporal average intensity was 600 W/cm2.Development of liver tumors in rats was induced by administration of Dimethylnitrosamin (100 ppm).Rats with liver tumors were anesthetized, underwent laparotomy, and were given the microbubble agent Levovist or saline intravenously.After 60 seconds of Levovist or saline injection, the liver was exposed to HIFU for 30 seconds. Immediately after HIFU exposure, ultrasound images of the HIFU area were evaluated. Then the liver was excised and the volume of coagulated tissue was measured.The mean volume of hyperechoic areas after HIFU were as follows (mm3, Levovist vs. saline : 355.3 ± 180.7 vs. 47.4 ± 35.6, p < 0.001, n=13).The volumes of liver tissue coagulated by HIFU were as follows (mm3, Levovist vs. saline : 275.3 ± 120.0 vs. 60.1 ± 23.6, p < 0.001, n=13).On microscopic examination of areas exposed to HIFU, implosion cysts were seen, and many cancer cells were found to have been disrupted or destroyed completely.Some tumor cells had been distorted by loss of cell membranes or nuclei.In conclusion, the microbubble agent Levovist, by increasing the effect of HIFU, could also have a direct role in anti-cancer therapy.
我们研究了使用高强度聚焦超声(HIFU)与微泡剂一起治疗肝细胞癌的可能性。HIFU 的换能器直径为 40 毫米;它产生连续的2.18-MHz波30秒。空间峰值时间平均强度为600 W/cm2。通过给予二甲基亚硝胺(100 ppm)诱导大鼠肝肿瘤的发展。将患有肝肿瘤的大鼠麻醉,进行剖腹手术,并静脉注射微泡剂Levovis或生理盐水。60秒后 Levovist 或盐水注射后,肝脏暴露于 HIFU 30 秒。 HIFU 暴露后,立即评估 HIFU 区域的超声图像。然后切除肝脏并测量凝固组织的体积。HIFU后高回声区域的平均体积如下(mm3,Levovis vs.生理盐水:355.3±180.7 vs.47.4±35.6,p <0.001,n=13)。HIFU凝固的肝组织体积如下(mm3,Levovis vs.生理盐水:355.3±180.7 vs.47.4±35.6,p <0.001,n=13)。 275.3 ± 120.0 vs. 60.1 ± 23.6, p < 0.001, n=13)。在显微镜检查暴露于 HIFU 的区域时,可以看到内爆囊肿,发现许多癌细胞已被完全破坏或破坏。一些肿瘤细胞因细胞膜或细胞核的丢失而扭曲。综上所述,微泡剂 Levovist 通过增强 HIFU 也可以在抗癌治疗中发挥直接作用。

项目成果

期刊论文数量(64)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue
  • DOI:
    10.1007/s00330-005-2663-7
  • 发表时间:
    2005-07-01
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    Kaneko, Y;Maruyama, T;Matsumoto, Y
  • 通讯作者:
    Matsumoto, Y
Polyacrylamide gel containing egg white as new model for irradiation experiments using focused ultrasound
  • DOI:
    10.1016/j.ultrasmedbio.2004.07.016
  • 发表时间:
    2004-10-01
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Takegami, K;Kaneko, Y;Nagawa, H
  • 通讯作者:
    Nagawa, H
18F-FDG PET for hepatocellular carcinoma presenting with portal vein thrombus.
18F-FDG PET 用于诊断伴有门静脉血栓的肝细胞癌。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hanajiri K;Mitsui H;Maruyama T;Kondo Y;Shiina S;Omata M;Nakagawa K.
  • 通讯作者:
    Nakagawa K.
Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice
  • DOI:
    10.1002/hep.1840380408
  • 发表时间:
    2003-10
  • 期刊:
  • 影响因子:
    13.5
  • 作者:
    T. Tsutsumi;Tetsuro Suzuki;K. Moriya;Y. Shintani;H. Fujie;H. Miyoshi;Y. Matsuura;K. Koike;T. Miyamura
  • 通讯作者:
    T. Tsutsumi;Tetsuro Suzuki;K. Moriya;Y. Shintani;H. Fujie;H. Miyoshi;Y. Matsuura;K. Koike;T. Miyamura
Anti-HBs antibodies produced after liver transplantation : from the donor or the recipient?
肝移植后产生的抗-HBs抗体:来自供者还是受者?
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Maruyama T;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARUYAMA Toshiyuki其他文献

MARUYAMA Toshiyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARUYAMA Toshiyuki', 18)}}的其他基金

The comparison of virus genome and immune reaction between asymptomatic carriers and chronic hepatitis patients infected with HBV.
无症状携带者与乙型肝炎病毒感染者的病毒基因组及免疫反应比较
  • 批准号:
    13670495
  • 财政年份:
    2001
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The mechanism which causes fulminant hepatic failure after immune suppression therapy on HBV carrier patients
乙型肝炎病毒携带者免疫抑制治疗后导致暴发性肝衰竭的机制
  • 批准号:
    11670480
  • 财政年份:
    1999
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation for the development of vaccine against hepatitis C virus
丙型肝炎病毒疫苗的研制研究
  • 批准号:
    09670515
  • 财政年份:
    1997
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Microbubble-ZPDGFRβ/PFD/liposome通过靶向肝星状细胞改善肿瘤微环境抑制肝细胞癌复发转移的作用及机制研究
  • 批准号:
    82272000
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
超声微泡造影剂携靶基因治疗及其声像图监控研究
  • 批准号:
    30430230
  • 批准年份:
    2004
  • 资助金额:
    130.0 万元
  • 项目类别:
    重点项目
超声微泡介导基因转染过程适宜空化效果的研究
  • 批准号:
    30400419
  • 批准年份:
    2004
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
超声微泡造影剂介导靶基因治疗梗死性血管病及机制研究
  • 批准号:
    30370402
  • 批准年份:
    2003
  • 资助金额:
    21.0 万元
  • 项目类别:
    面上项目

相似海外基金

ERI:Elucidating the Mechanism and Effects of Enhanced Thermal Ablation of Tissues by Microbubble Assisted High Intensity Focused Ultrasound
ERI:阐明微泡辅助高强度聚焦超声增强组织热消融的机制和效果
  • 批准号:
    2301721
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Standard Grant
Establishment of Ultrasound Control Technique of Microbubble-Encapsulated Vesicles and Its Medical Applications
微泡囊泡超声控制技术的建立及其医学应用
  • 批准号:
    23H00164
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of Carbon Dioxide Resource Conversion Technology Using Microbubble In-liquid Plasma
利用微气泡液态等离子体开发二氧化碳资源转化技术
  • 批准号:
    23K17065
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Light-based controls of giant temperature gradient on a microbubble surface
基于光的微泡表面巨大温度梯度控制
  • 批准号:
    23H01723
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Treatment of Alzheimer’s Disease using Ultrasound-Targeted Microbubble Cavitation-Mediated Blood Brain Barrier Opening to Facilitate Drug Delivery to the Brain
使用超声靶向微泡空化介导的血脑屏障打开促进药物输送至大脑来治疗阿尔茨海默病
  • 批准号:
    10462037
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
Treatment of Alzheimer’s Disease using Ultrasound-Targeted Microbubble Cavitation-Mediated Blood Brain Barrier Opening to Facilitate Drug Delivery to the Brain
使用超声靶向微泡空化介导的血脑屏障打开促进药物输送到大脑来治疗阿尔茨海默病
  • 批准号:
    10710373
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
OPTIMUM (Oxidative Flow Platform Utilising Porous liquids, 3D printing and Microbubble Technology at Almac)
OPTIMUM(Almac 利用多孔液体、3D 打印和微泡技术的氧化流平台)
  • 批准号:
    MR/W001764/1
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Fellowship
Microbubble resonator dispersion engineering for blue-band soliton comb generation
用于蓝带孤子梳生成的微泡谐振器色散工程
  • 批准号:
    22K14621
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Understanding the vascular physiology after exposure to ultrasound stimulated microbubble oscillations
了解暴露于超声波刺激的微泡振荡后的血管生理学
  • 批准号:
    RGPIN-2018-04233
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Discovery Grants Program - Individual
Determining the biochemical mechanism of microbubble-mediated vascular permeability
确定微泡介导的血管通透性的生化机制
  • 批准号:
    RGPIN-2018-06505
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了